Jourdain, Hugo http://orcid.org/0000-0001-8035-7517
Hoisnard, Léa http://orcid.org/0000-0002-0921-5142
Sbidian, Emilie http://orcid.org/0000-0002-1267-5270
Zureik, Mahmoud http://orcid.org/0000-0002-8393-4217
Funding for this research was provided by:
Agence Nationale de Sécurité du Médicament et des Produits de Santé
Caisse Nationale d'Assurance Maladie
Assistance Publique - Hôpitaux de Paris
Article History
Accepted: 7 February 2023
First Online: 6 March 2023
Declarations
:
: The authors are employees of the French National Health Insurance (CNAM), the French National Agency for Medicines and Health Products Safety (ANSM) and the Assistance Publique-Hôpitaux de Paris (AP-HP) and received no funding for this study. The funding source did not intervene at any step of the study.
: Hugo Jourdain, Léa Hoisnard, Emilie Sbidian, and Mahmoud Zureik have no conflicts of interest to report.
: EPI-PHARE has permanent regulatory access to the data via its constitutive bodies ANSM and CNAM, thus this present work did not require approval from the French Data Protection Authority (CNIL). The study was registered on the EPI-PHARE study register.
: Given that the data are anonymous, no informed consent to participate or publish was required.
: In accordance with data protection legislation and the French regulation, the authors cannot publicly release the data from the French National Health Data System.
: Not applicable.
: Literature search: All authors. Study design: All authors. Data extraction and collection: HJ. Statistical analysis: HJ. Interpretation of the results. All authors. Drafting of the manuscript: HJ. Revision of the manuscript. All authors. Supervision: ES, MZ. All authors confirm that they had full access to all the data in the study and accept responsibility to submit the manuscript for publication.